Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients

Circulating tumor DNA (ctDNA) has been suggested as a surrogate biomarker for early detection of cancer recurrence. We aimed to explore the utility of ctDNA as a noninvasive prognostic biomarker in newly diagnosed head and neck squamous cell carcinoma (HNSCC) patients. Seventy HNSCC specimens were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kampel, Liyona, Feldstein, Sara, Tsuriel, Shlomo, Hannes, Victoria, Carmel Neiderman, Narin N., Horowitz, Gilad, Warshavsky, Anton, Leider-Trejo, Leonor, Hershkovitz, Dov, Muhanna, Nidal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527516/
https://www.ncbi.nlm.nih.gov/pubmed/37759818
http://dx.doi.org/10.3390/biom13091418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527516/
https://www.ncbi.nlm.nih.gov/pubmed/37759818
http://dx.doi.org/10.3390/biom13091418

Ejemplares similares